InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Friedman Paul A, Director. Insider active across 3 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 16 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €422k. History available since 20 May 2021. The latest transaction was disclosed on 9 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Friedman Paul A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
280 shares@ US$15.800.1% of flowCommon StockSEC:0001628280-26-001981:0
24,520 shares@ US$15.809.9% of flowCommon StockSEC:0001628280-26-001976:0
24,800 shares@ US$15.8011.1% of flowCommon StockSEC:0001628280-25-056794:0
129,172 shares@ US$9.4538.7% of flowCommon StockSEC:0001236927-25-000007:0
3,203 shares@ US$9.451.0% of flowCommon StockSEC:0001236927-25-000005:0
1,400 shares@ US$9.450.8% of flowCommon StockSEC:0001628280-25-035580:0
1,400 shares@ US$350.031429.9% of flowCommon StockSEC:0001628280-25-035580:1
26,176 shares@ US$9.4513.1% of flowCommon StockSEC:0001628280-25-035342:0
715 shares0Common StockSEC:0001628280-25-032846:0
714 shares0Common StockSEC:0000950170-24-078748:0
26,270 shares@ US$9.4516.2% of flowCommon StockSEC:0000950170-24-043502:0
27,407 shares@ US$9.4517.0% of flowCommon StockSEC:0000899243-24-000265:0
2,254 shares@ US$243.9236.1% of flowCommon StockSEC:0000950170-24-005297:0
26,668 shares0Common StockSEC:0000899243-23-002095:0
12,840 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000075:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000046:0
16 of 16 declarations
About Friedman Paul A
Paul A. Friedman is a Director at Madrigal Pharmaceuticals, INC. and ALEXION PHARMACEUTICALS, INC. He has 16 filings in total, and among the recent filings covered, transactions run from 2021-05-24 to 2026-01-13, with EUR 421889 in sales and a modal transaction nature of Option exercise.
